D. Chamith Halahakoon
University College London
10 Papers
3 Citations
D. Chamith Halahakoon is an academic researcher from University College London. The author has contributed to research in topics: Major depressive disorder & Medicine. The author has an hindex of 4, co-authored 7 publications. Previous affiliations of D. Chamith Halahakoon include University of Oxford.
Chat about Author
Papers
Reward-Processing Behavior in Depressed Participants Relative to Healthy Volunteers: A Systematic Review and Meta-analysis.
D. Chamith Halahakoon,D. Chamith Halahakoon,Karel Kieslich,Ciarán O'Driscoll,Akshay Nair,Akshay Nair,Glyn Lewis,Jonathan P. Roiser +7 more
TL;DR: It is found that depression is associated with behavioral reward-processing impairments, although this could vary depending on the precise subcomponent measured.
Neural predictors of treatment response to brain stimulation and psychological therapy in depression: a double-blind randomized controlled trial.
Camilla L. Nord,Camilla L. Nord,D. Chamith Halahakoon,D. Chamith Halahakoon,Tarun Limbachya,Caroline J. Charpentier,Caroline J. Charpentier,Níall Lally,Níall Lally,Níall Lally,Vincent Walsh,Judy Leibowitz,Stephen Pilling,Stephen Pilling,Jonathan P. Roiser +14 more
TL;DR: A mechanistic trial revealed variable, but predictable, clinical effects of prefrontal tDCS combined with CBT for depression and discovered a potential explanation for this variability: individual differences in baseline activation of the region stimulated.
73
Prefrontal cortex stimulation does not affect emotional bias, but may slow emotion identification
Camilla L. Nord,Sophie Forster,D. Chamith Halahakoon,Ian S. Penton-Voak,Marcus R. Munafò,Jonathan P. Roiser +5 more
TL;DR: Insight is provided into the possible mechanisms by which DLPFC tDCS may treat symptoms of depression, suggesting that it may not alter emotional biases, but instead may affect ‘cold’ cognitive processes.
Cognitive impairment in depression and its (non-)response to antidepressant treatment
TL;DR: This was a longitudinal, randomised, open-label trial assessing the effects of three antidepressant drugs on cognitive function in depressed individuals, and whether standard antidepressant treatment improves Cognitive function in depression.